Publication | Closed Access

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus

Cervical Cancer ManagementCervical Cancer ScreeningCervical CancerCervical HealthHuman Papillomavirus VaccinesCancer ScreeningHealth EconomicsCancer DetectionGynecologyCytopathologyCost EffectivenessPublic HealthHuman Immunodeficiency VirusMedicineEpidemiologyCervical Cancer Prevention